TCG Crossover GP II, LLC 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:14 pm Purchase | 2025-06-30 | 13G | Nektar Therapeutics NKTR | TCG Crossover GP II, LLC | 1,933,333 9.300% | 596,910 (+44.66%) | Filing |
| 2024-03-15 4:18 pm Purchase | 2024-03-06 | 13G | Nektar Therapeutics NKTR | TCG Crossover GP II, LLC | 1,336,423 9.900% | 1,336,423 (New Position) | Filing |